Noor Ul Ain Rehman
Sat, June 27, 2026 astatine 2:09 PM CDT 2 min read
Boston Scientific Corporation (NYSE:BSX) besides received a standing update from Canaccord connected June 1. The steadfast lowered the terms people connected the banal to $70 from $71, reiterating a Buy standing connected the shares. Canaccord stated that it updated its exemplary connected the banal to instrumentality into relationship slowdowns successful the U.S. Watchman concern successful 2026 and 2027, which person antagonistic implications connected its gross and EPS estimates.
Boston Scientific Corporation (NYSE:BSX) manufactures, develops, and markets aesculapian devices utilized successful interventional aesculapian procedures. Its operations are divided into Cardiovascular and MedSurg segments. The Cardiovascular conception covers Cardiology and Peripheral Interventions, portion the MedSurg conception comprises Urology, Endoscopy, and Neuromodulation.
While we admit the imaginable of BSX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.
READ NEXT: 15 Stocks That Will Make You Rich successful 10 Years AND 12 Best Stocks That Will Always Grow.
Disclosure: None. Follow Insider Monkey connected Google News.

1 day ago
3





English (CA) ·
English (US) ·
Spanish (MX) ·